Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Pilot Study of NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer

NCT00749346 is registered in ClinicalTrials.gov with NovoCure Ltd. as lead sponsor.

NCT NCT00749346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00749346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Pilot Study of NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer
Lead sponsor
NovoCure Ltd.
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2008
Completion date
July 31, 2011
Enrollment
42 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer, nsclc